Reckitt Benckiser Group (LON:RB) had its price objective reduced by equities research analysts at Barclays from GBX 6,700 ($88.13) to GBX 6,400 ($84.19) in a note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Barclays‘s target price suggests a potential upside of 3.68% from the company’s previous close.

A number of other research firms have also issued reports on RB. Deutsche Bank reissued a “buy” rating and set a GBX 7,200 ($94.71) price target on shares of Reckitt Benckiser Group in a research report on Thursday, February 27th. Goldman Sachs Group raised their price target on shares of Reckitt Benckiser Group from GBX 5,800 ($76.30) to GBX 6,000 ($78.93) and gave the stock a “neutral” rating in a research report on Tuesday. UBS Group reduced their price target on shares of Reckitt Benckiser Group from GBX 6,100 ($80.24) to GBX 5,700 ($74.98) and set a “neutral” rating for the company in a research report on Wednesday, March 4th. Kepler Capital Markets reduced their price target on shares of Reckitt Benckiser Group from GBX 6,950 ($91.42) to GBX 6,600 ($86.82) and set a “buy” rating for the company in a research report on Tuesday, March 3rd. Finally, Morgan Stanley reissued a “buy” rating and set a GBX 6,600 ($86.82) price target on shares of Reckitt Benckiser Group in a research report on Monday. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of GBX 6,355 ($83.60).

RB traded up GBX 223 ($2.93) during trading on Tuesday, reaching GBX 6,173 ($81.20). 4,044,904 shares of the company’s stock were exchanged, compared to its average volume of 1,720,000. Reckitt Benckiser Group has a 1 year low of GBX 5,510 ($72.48) and a 1 year high of GBX 8,191.30 ($107.75). The company has a debt-to-equity ratio of 130.80, a current ratio of 0.56 and a quick ratio of 0.41. The stock has a market capitalization of $44.22 billion and a P/E ratio of -11.88. The company’s fifty day simple moving average is GBX 6,093.46 and its 200-day simple moving average is GBX 6,103.72.

In other news, insider Laxman Narasimhan bought 17,241 shares of the business’s stock in a transaction dated Tuesday, March 3rd. The stock was purchased at an average cost of GBX 5,800 ($76.30) per share, with a total value of £999,978 ($1,315,414.36).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: What is the Russell 2000 Index?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.